Find link

language:

Find link is a tool written by Edward Betts.

searching for Tenofovir disoproxil 15 found (62 total)

Pre-exposure prophylaxis for HIV prevention (7,897 words) [view diff] exact match in snippet view article find links to article

74%. The first form of PrEP for HIV prevention - emtricitabine and tenofovir disoproxil (FTC/TDF; Truvada) - was approved in 2012. In October 2019, the US

HPTN 083 (399 words) [view diff] case mismatch in snippet view article find links to article

Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), For Pre-Exposure Prophylaxis in

Chloe Orkin (1,733 words) [view diff] case mismatch in snippet view article find links to article

2019). "Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate is Non-inferior to Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-naive

Thomas D. Schiano (1,624 words) [view diff] case mismatch in snippet view article find links to article

clinical trial A Rollover Protocol to Provide Open-Label Emtricitabine/Tenofovir Disoproxil Fumarate Combination Product to Subjects Completing the GS-US-203-0107

Elioda Tumwesigye (1,962 words) [view diff] case mismatch in snippet view article find links to article

risk of Proximal Tubular Dysfunction associated with Emtricitabine-Tenofovir Disoproxil Fumarate Preexposure Prophylaxis in men and women. the study found

Multidrug resistance-associated protein 2 (1,709 words) [view diff] exact match in snippet view article find links to article

hepatobiliary elimination but not the intestinal disposition of tenofovir disoproxil fumarate and its metabolites". Xenobiotica. 35 (10–11): 1055–66.

John C. Martin (businessman) (1,443 words) [view diff] case mismatch in snippet view article

CBSN. Retrieved 23 March 2017. "Atripla (Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate) Tablets". U.S. Food and Drug Administration. Retrieved

HIV disease–related drug reaction (3,030 words) [view diff] exact match in snippet view article find links to article

patients taking the first line antiretroviral therapy of efavirenz/tenofovir disoproxil fumarate/emtricitabine fixed‐dose combination. Other reported risk

Post-exposure prophylaxis (3,344 words) [view diff] exact match in snippet view article find links to article

emtricitabine/tenofovir pills containing 200 mg of emtricitabine and 245 mg of tenofovir disoproxil to be taken once daily, and 400 mg pills of raltegravir to be taken

Jeffrey P. Nadler (1,092 words) [view diff] exact match in snippet view article find links to article

Syndromes. 2002;31:483-487. Squires K, Pozniak AL, Pierone G, et al. Tenofovir disoproxil fumarate in nucleoside-resistant HIV-1 infection. Ann Intern Med

Gladstone Institutes (2,796 words) [view diff] exact match in snippet view article find links to article

20, 2021. "Drug Approval Package: Truvada (emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) NDA #021752Orig1s030". www.accessdata.fda.gov. Retrieved

Gladstone Institutes (2,796 words) [view diff] exact match in snippet view article find links to article

20, 2021. "Drug Approval Package: Truvada (emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) NDA #021752Orig1s030". www.accessdata.fda.gov. Retrieved

Raymond F. Schinazi (2,571 words) [view diff] exact match in snippet view article find links to article

restoration of functional immunity. In addition, FTC in combination with tenofovir disoproxil fumarate (Truvada) was approved as a prophylactic drug (part of PrEP)

HIV Prevention Trials Network (3,596 words) [view diff] case mismatch in snippet view article find links to article

Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), For Pre-Exposure Prophylaxis in

Timeline of HIV/AIDS (13,023 words) [view diff] exact match in snippet view article find links to article

patients with HIV failed to respond to the antiviral drug known as Tenofovir disoproxil. Tenofovir is the main HIV drug treatment. The failure to respond